194 related articles for article (PubMed ID: 36157699)
1. Sotorasib Shows Intracranial Activity in Patients with
Koster KL; Appenzeller C; Lauber A; Früh M; Schmid S
Case Rep Oncol; 2022; 15(2):720-725. PubMed ID: 36157699
[TBL] [Abstract][Full Text] [Related]
2. Remarkable Intracranial Response to Sotorasib in a Patient With
Yeh J; Marks JA; Alzeer AH; Sloan EA; Varghese R; Paudel N; Reuss JE; Bergquist PJ; Liu SV; Kim C
JTO Clin Res Rep; 2022 Dec; 3(12):100428. PubMed ID: 36471683
[TBL] [Abstract][Full Text] [Related]
3. Activity of sotorasib against brain metastases from NSCLC harboring
Inno A; Marchetti F; Valerio M; Giaj Levra N; Alongi F; Foti G; Gori S
Drug Target Insights; 2023; 17():90-91. PubMed ID: 37408855
[TBL] [Abstract][Full Text] [Related]
4. Mixed response to the first-line treatment of KRAS G12C inhibitor, sotorasib, in non-small cell lung cancer: A brief report.
Yang J; Huang J; Yuan G; Lin XC; Chen HJ; Yang JJ
Clin Case Rep; 2024 Jun; 12(6):e8866. PubMed ID: 38799516
[TBL] [Abstract][Full Text] [Related]
5. Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer.
Lee A
Target Oncol; 2022 Nov; 17(6):727-733. PubMed ID: 36315377
[TBL] [Abstract][Full Text] [Related]
6. Sotorasib as First-Line Treatment for Advanced KRAS G12C-Mutated Non-Small Cell Lung Carcinoma: A Case Report.
Iska S; Alley EW
Case Rep Oncol; 2023; 16(1):177-181. PubMed ID: 37008835
[TBL] [Abstract][Full Text] [Related]
7. CodeBreak 200: Sotorasib Has Not Broken the KRAS
Zhang SS; Lee A; Nagasaka M
Lung Cancer (Auckl); 2023; 14():27-30. PubMed ID: 37101895
[TBL] [Abstract][Full Text] [Related]
8. CodeBreaK 200: Sotorasib (AMG510) Has Broken the
Brazel D; Kim J; Ou SI
Lung Cancer (Auckl); 2023; 14():31-39. PubMed ID: 37101896
[TBL] [Abstract][Full Text] [Related]
9. KRAS Inhibitor Resistance in
Suzuki S; Yonesaka K; Teramura T; Takehara T; Kato R; Sakai H; Haratani K; Tanizaki J; Kawakami H; Hayashi H; Sakai K; Nishio K; Nakagawa K
Clin Cancer Res; 2021 Oct; 27(20):5697-5707. PubMed ID: 34365406
[TBL] [Abstract][Full Text] [Related]
10. Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany.
Stratmann JA; Althoff FC; Doebel P; Rauh J; Trummer A; Hünerlitürkoglu AN; Frost N; Yildirim H; Christopoulos P; Burkhard O; Büschenfelde CMZ; Becker von Rose A; Alt J; Aries SP; Webendörfer M; Kaldune S; Uhlenbruch M; Tritchkova G; Waller CF; Rittmeyer A; Hoffknecht P; Braess J; Kopp HG; Grohé C; Schäfer M; Schumann C; Griesinger F; Kuon J; Sebastian M; Reinmuth N
Eur J Cancer; 2024 Apr; 201():113911. PubMed ID: 38377774
[TBL] [Abstract][Full Text] [Related]
11. FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC.
Nakajima EC; Drezner N; Li X; Mishra-Kalyani PS; Liu Y; Zhao H; Bi Y; Liu J; Rahman A; Wearne E; Ojofeitimi I; Hotaki LT; Spillman D; Pazdur R; Beaver JA; Singh H
Clin Cancer Res; 2022 Apr; 28(8):1482-1486. PubMed ID: 34903582
[TBL] [Abstract][Full Text] [Related]
12. Editorial: Recent Approval of Sotorasib as the First Targeted Therapy for KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC).
Parums DV
Med Sci Monit; 2022 Nov; 28():e938746. PubMed ID: 36317327
[TBL] [Abstract][Full Text] [Related]
13. BCL-X
Khan S; Wiegand J; Zhang P; Hu W; Thummuri D; Budamagunta V; Hua N; Jin L; Allegra CJ; Kopetz SE; Zajac-Kaye M; Kaye FJ; Zheng G; Zhou D
J Hematol Oncol; 2022 Mar; 15(1):23. PubMed ID: 35260176
[TBL] [Abstract][Full Text] [Related]
14. Sotorasib: a treatment for non-small cell lung cancer with the KRAS G12C mutation.
Zheng X; Luo J; Liu W; Ashby CR; Chen ZS; Lin L
Drugs Today (Barc); 2022 Apr; 58(4):175-185. PubMed ID: 35412531
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated
Dy GK; Govindan R; Velcheti V; Falchook GS; Italiano A; Wolf J; Sacher AG; Takahashi T; Ramalingam SS; Dooms C; Kim DW; Addeo A; Desai J; Schuler M; Tomasini P; Hong DS; Lito P; Tran Q; Jones S; Anderson A; Hindoyan A; Snyder W; Skoulidis F; Li BT
J Clin Oncol; 2023 Jun; 41(18):3311-3317. PubMed ID: 37098232
[No Abstract] [Full Text] [Related]
16. Rapid Response to Sotorasib of a Patient With
Kunimasa K; Tamiya M; Inoue T; Kawamura T; Nishino K
JTO Clin Res Rep; 2023 Jan; 4(1):100442. PubMed ID: 36619890
[TBL] [Abstract][Full Text] [Related]
17. Sotorasib in
Strickler JH; Satake H; George TJ; Yaeger R; Hollebecque A; Garrido-Laguna I; Schuler M; Burns TF; Coveler AL; Falchook GS; Vincent M; Sunakawa Y; Dahan L; Bajor D; Rha SY; Lemech C; Juric D; Rehn M; Ngarmchamnanrith G; Jafarinasabian P; Tran Q; Hong DS
N Engl J Med; 2023 Jan; 388(1):33-43. PubMed ID: 36546651
[TBL] [Abstract][Full Text] [Related]
18. Brief report on the efficacy of sotorasib in KRAS-Mutated NSCLC patients with brain metastases.
Lebouille-Veldman AB; Taros TN; Nawabi NLA; Mekary RA; Peng L; Phillips J
Lung Cancer; 2024 Jan; 187():107425. PubMed ID: 38061200
[TBL] [Abstract][Full Text] [Related]
19. Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program.
Passiglia F; Lucia Reale M; Lo Russo G; Pasello G; Minuti G; Bulotta A; Galetta D; Pelizzari G; Sini C; Bria E; Roca E; Pilotto S; Genova C; Metro G; Citarella F; Chiari R; Cortinovis D; Delmonte A; Russo A; Tiseo M; Cerea G; Carta A; Scotti V; Vavalà T; Brambilla M; Buffoni L; Buosi R; Catania C; Gori S; Grisanti S; Agustoni F; Garbo E; Malapelle U; Novello S
Lung Cancer; 2024 Jan; 187():107444. PubMed ID: 38157806
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]